Hip Fracture Prevention in Geriatric Patients with Osteoporosis

Primary Pharmacological Interventions

The American College of Rheumatology recommends pharmacological treatment with bisphosphonates (alendronate or risedronate) combined with calcium (1000-1200 mg/day) and vitamin D (800 IU/day) supplementation to reduce hip fractures in elderly osteoporotic patients, reducing subsequent fracture risk by approximately 50% over 3 years and hip fractures specifically by 40% 1, 2, 3
Bisphosphonates (alendronate or risedronate) are the preferred first-choice agents due to tolerability, low cost from generic availability, and extensive clinical experience 4
Treatment with bisphosphonates should be started within the first 6 months post-fracture to maximize benefit during the period of highest subsequent fracture risk 5
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis recommends regularly monitoring for tolerance and adherence, as long-term compliance is often poor 2, 4

Calcium 1000-1200 mg/day combined with vitamin D 800 IU/day reduces non-vertebral fractures by 15-20% and falls by 20% 3
The National Osteoporosis Foundation advises against using high-pulse dosages of vitamin D, as these increase fall risk rather than prevent it 3
Early postfracture introduction of physical training and muscle strengthening is effective in preventing fractures 1, 2
The American Geriatrics Society recommends long-term continuation of balance training and multidimensional fall prevention 1, 2

The International Osteoporosis Foundation recommends systematic evaluation for every patient aged 50+ with a fragility fracture, including review of clinical risk factors for subsequent fractures, DXA scanning of spine and hip, and imaging of the spine for vertebral fractures 1, 2
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis advises evaluating falls risk through comprehensive assessment and identifying secondary causes of osteoporosis 1, 2
Multidisciplinary coordination, including liaison between surgeons, rheumatologists/endocrinologists, geriatricians, and general practitioners, is essential for secondary fracture prevention 1, 2
Orthogeriatric comanagement should be provided, especially for elderly patients with hip fracture, to improve functional outcomes, reduce length of hospital stay, and reduce mortality 2

Patients should be educated about disease burden, risk factors for fractures, follow-up requirements, and expected duration of therapy 1, 2, 4
The National Osteoporosis Foundation emphasizes that fracture risk remains acutely elevated for 24 months before gradually declining 5

The American College of Rheumatology advises against waiting for "perfect consolidation" to initiate osteoporosis therapy—start bisphosphonates immediately to avoid the osteoporosis care gap 5
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis recommends against delaying fracture risk assessment and osteoporosis treatment in patients who have already sustained a fragility fracture 4